Sanofi-Aventis Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Sanofi-Aventis (formerly Sanofi-Synthelabo) covers the period ending October 22, 2004. The report discloses a specific corporate action regarding a mandatory tender offer for shares of Hoechst Aktiengesellschaft.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific transaction update and does not contain financial statements or performance metrics.
Material Changes
As of October 21, 2004, at 18:00 hours (CET), Sanofi-Aventis's mandatory offer for Hoechst Aktiengesellschaft shares was accepted for 62,121 shares. This represents less than 0.01% of the share capital and voting rights of Hoechst Aktiengesellschaft.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It does not disclose specific risks or contingencies beyond the status of the ongoing mandatory offer.
Key Facts for Investor Verification
- Sanofi-Aventis initiated a mandatory offer for Hoechst Aktiengesellschaft shares.
- As of the cutoff date, only 62,121 shares were tendered.
- The tendered shares represent less than 0.01% of Hoechst's total share capital and voting rights.
- No financial performance data is included in this specific filing.